MMF Versus CYC in the Induction Therapy of Pediatric Active Proliferative LN
- Status
- UNKNOWN
- Phase
- PHASE4
Clinical Trials Related to Lupus Nephritis
Related studies linked through entity extraction aliases.
Disease Activity Biomarkers in Patients With Systemic Lupus Erythematosus
- Status
- RECRUITING
- Phase
- N/A
Efficiency of Use of Baracetinib in Treatment of Lupus Nephritis
- Status
- UNKNOWN
- Phase
- PHASE3
Precision Medicine in LN: A Multicenter Proof-of-concept Study for Histopathological Biomarkers Analysis in Renal Biopsy
- Status
- UNKNOWN
- Phase
- N/A
A Prospective Observational Registry of Patients Treated With LUPKYNIS® (Voclosporin) in the US
- Status
- COMPLETED
- Phase
- N/A
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- Status
- RECRUITING
- Phase
- PHASE2
Open-label Extension Study of Efficacy, Safety and Tolerability of Secukinumab in Patients With Active Lupus Nephritis
- Status
- TERMINATED
- Phase
- PHASE3
Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus Nephritis
- Status
- RECRUITING
- Phase
- PHASE4
VIBRANT: VIB4920 for Active Lupus Nephritis
- Status
- RECRUITING
- Phase
- PHASE2
A Pharmacoeconomic Study Comparing the Use of Mycophenolate Mofetil or Cyclophosphamide as Induction Therapy in Lupus Nephritis Patients in Egypt
- Status
- COMPLETED
- Phase
- N/A
Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Epidemiology of Lupus Nephritis in Nephrology Unit in Assiut University Hospital
- Status
- UNKNOWN
- Phase
- N/A
Pharmacokinetically-driven Dosing of Mycophenolate Mofetil for the Treatment of Pediatric Proliferative Lupus Nephritis
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)
- Status
- TERMINATED
- Phase
- PHASE2
A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Immune Nephritis
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
The Expression Profile of New Complement Components in Childhood Lupus Nephritis
- Status
- UNKNOWN
- Phase
- N/A
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
- Status
- RECRUITING
- Phase
- PHASE2
A Phase II Study to Evaluate the Efficacy and Safety of SHR-1314 in Lupus Nephritis
- Status
- UNKNOWN
- Phase
- PHASE2
Urine Exosomes to Identify Biomarkers for LN
- Status
- UNKNOWN
- Phase
- N/A